The Discounted Cash Flow (DCF) valuation of Bharat Immunologicals and Biologicals Corporation Ltd (524663.BO) is (21.40) INR. With the latest stock price at 23.22 INR, the upside of Bharat Immunologicals and Biologicals Corporation Ltd based on DCF is -192.2%.
Based on the latest price of 23.22 INR and our DCF valuation, Bharat Immunologicals and Biologicals Corporation Ltd (524663.BO) is a sell. selling 524663.BO stocks now will result in a potential gain of 192.2%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 9.3% - 25.4% | 17.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (28.34) - (19.97) | (21.40) |
| Upside | -222.1% - -186.0% | -192.2% |